04:57 AM EDT, 06/06/2024 (MT Newswires) -- Telix Pharmaceuticals ( TLPPF ) said Wednesday it has launched an initial public offering in the US of 17 million American depositary shares, each representing one ordinary share, for expected gross proceeds of $200 million.

The company plans to grant the underwriters a 30-day option to buy up to an additional 15% of the number of shares sold in the offering.

Telix has applied to list its ADSs on the Nasdaq Global Market under the ticker symbol "TLX." Its ordinary shares will continue to trade on the Australian Securities Exchange.